Atlantic Research Group

ARG, founded in 2004, is a contract research organization focused on oncology, immunology, and neurology, providing comprehensive clinical program development services ranging from planning to commercialization, and achieving over 50 market authorizations to date. Built on the vision that every project should be highly individualized, ARG has experienced consistent global growth, expanding its range to include drug and device strategic consulting, clinical trial management services, and advanced clinical data and analytic solutions. ARG uses first-in-class technology platforms along with relationship-driven flexibility to optimize clinical studies—because we believe everyone deserves to be well. In 2025, ARG entered a new chapter through a strategic merger with Evestia Clinical. Moving forward under the Evestia Clinical brand, the combined organization forms a leading mid-tier CRO with expanded global reach, enhanced therapeutic expertise, and a full-service clinical trial offering.